Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/11/2012US8263091 Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
09/11/2012US8263089 Compounds and methods for treatment and diagnosis of chlamydial infection
09/11/2012US8263082 Chemically programmable immunity
09/11/2012US8263080 Use of agonists and antagonists of IL-23 in the treatment of viral infection
09/11/2012US8263077 Cell growth inhibitors containing anti-glypican 3 antibody
09/11/2012US8263069 Compositions including anthocyanin or anthocyanidin for the prevention or treatment of articular cartilage-associated conditions
09/11/2012US8263067 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy
09/11/2012US8263066 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
09/11/2012US8263063 Multimeric VLA-4 antagonists comprising polymer moieties
09/11/2012US8263062 Multi-arm polymer prodrugs
09/11/2012US8263060 Fast degrading polymers
09/11/2012US8263059 Compositions and kits for the removal of irritating compounds from bodily surfaces
09/11/2012US8263058 Personal care compositions that deposit hydrophilic benefit agents
09/11/2012US8263054 Method of enhancing hair growth
09/11/2012US8263050 Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions
09/11/2012US8263047 Topical anesthetic for dental procedures
09/11/2012US8263046 4-methoxy-N-phenyl-N-[2-(pyridin-2-yl)ethyl]benz(enesulfon)amide and a second cooling agent, such as menthol or a derivative; similar cooling intensity to N-ethyl p-menthanecarboxamide (WS-3); ingestible or topical
09/11/2012US8263044 Stilbene like compounds as novel HDAC inhibitors
09/11/2012US8263042 Contrast agents for myocardial perfusion imaging
09/11/2012US8262948 Intraocular lenses with combinations of UV absorbers and blue light chromophores
09/11/2012US8262947 UV/visible light absorbers for ophthalmic lens materials
09/11/2012US8262938 Active aluminum rich coatings
09/11/2012US8262054 Furnace mount
09/11/2012CA2751002C Method for treatment of diseases
09/11/2012CA2699908C Resveratrol-containing compositions for modulating gene product concentration or activity
09/11/2012CA2673988C Stable s-nitrosothiols, method of synthesis and use
09/11/2012CA2668524C New process for synthesizing 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one and its application to the synthesis of ivrabadine and its addition salts to an acceptable pharmaceutical acid
09/11/2012CA2627740C Preparation of a crystalline antibiotic substance
09/11/2012CA2596679C Method of treating ischemia-reperfusion injury
09/11/2012CA2588732C External patches containing etofenamate
09/11/2012CA2587280C Particle-size reduction apparatus, and use thereof
09/11/2012CA2567479C Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
09/11/2012CA2561167C Composition of solifenacin or salt thereof for use in solid formulation
09/11/2012CA2556586C Thiol ester compositions and processes for making and using same
09/11/2012CA2551640C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
09/11/2012CA2543351C Amide derivatives
09/11/2012CA2540040C Rapidly disintegrating formulation
09/11/2012CA2534120C Medicaments for inhalation comprising anticholinergics and a betamimetic
09/11/2012CA2533792C Medicaments for inhalation comprising steroids and fluorene carboxylic acid esters
09/11/2012CA2533598C Method for modulating calcium ion-release-activated calcium ion channels
09/11/2012CA2532450C Chlorthalidone combinations
09/11/2012CA2529367C Preventing atrial fibrillation (af) with the use of statin drugs
09/11/2012CA2526570C Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
09/11/2012CA2519112C Optimized expression of hpv 31 l1 in yeast
09/11/2012CA2513555C Process for the preparation of pyridylsulfinylbenzimidazoles
09/11/2012CA2508573C Novel coumarins, their carboxamide derivatives, preparation methods, compositions, and uses
09/11/2012CA2506296C Water-soluble anionic bacteriochlorophyll derivatives and their uses
09/11/2012CA2480881C Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
09/11/2012CA2478558C Naltrexone hydrochloride compositions
09/11/2012CA2475218C Preparation for oxidation-sensitive compounds and method for making same
09/11/2012CA2474402C Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
09/11/2012CA2466851C Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
09/11/2012CA2462557C Method of stabilizing reduced coenzyme q10
09/11/2012CA2417867C Methods of preventing or treating diseases and conditions using complex carbohydrates
09/11/2012CA2254082C Metastatic colorectal cancer vaccine
09/11/2012CA2233867C Vector and method of use for nucleic acid delivery to non-dividing cells
09/10/2012CA2733956A1 Compositions and methods for modulating circadian synchronization
09/08/2012CA2825519A1 Pyrrole derivatives used as modulators of alpha7 nachr
09/08/2012CA2771189A1 Novel dihydro-oxazolobenzodiazepinon derivatives, processes for their preparation and pharmaceutical compositions containing them
09/07/2012WO2012119151A2 Method and apparatus for alcohol administration
09/07/2012WO2012119078A2 COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE
09/07/2012WO2012119077A1 Co -administration of eribulin and farletuzumab for the treatment of breast cancer
09/07/2012WO2012119059A1 Non-aqueous silicone-based ophthalmic formulations
09/07/2012WO2012119056A1 Proteasome inhibitor delanzomib for use in the treatment of lupus
09/07/2012WO2012119051A2 Enhanced biodistribution of oligomers
09/07/2012WO2012119045A2 Compositions and uses thereof to ameliorate pain
09/07/2012WO2012119035A1 Anti-amyloid compounds and methods
09/07/2012WO2012119019A2 Method of extracting phenolic fractions of extra virgin olive oil
09/07/2012WO2012119010A2 Materials for inhibiting aromatase and method of using the same to diagnose, treat and monitor breast cancer
09/07/2012WO2012119006A2 Derivatives of pyrazole-substituted amino-heteroaryl compounds
09/07/2012WO2012118978A1 Methods for treating oncovirus positive cancers
09/07/2012WO2012118945A2 Fused bicyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
09/07/2012WO2012118935A1 Compounds for the treatment of neurodegenerative diseases
09/07/2012WO2012118915A2 Compositions and methods for treatment of tamoxifen resistant breast cancer
09/07/2012WO2012118850A1 Serine/threonine kinase inhibitors
09/07/2012WO2012118812A2 Substituted 6,5-fused bicyclic heteroaryl compounds
09/07/2012WO2012118794A2 Treatment of urinary incontinence using nitrone spin traps
09/07/2012WO2012118782A1 Histone deacetylase inhibitors
09/07/2012WO2012118704A1 Compositions and methods for non-surgical treatment of ptosis
09/07/2012WO2012118679A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/07/2012WO2012118599A1 C-abl tyrosine kinase inhibitors useful for inhibiting filovirus replication
09/07/2012WO2012118563A2 6-alkyl-n-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
09/07/2012WO2012118498A1 Compounds and methods for the treatment of pain and other disorders
09/07/2012WO2012118492A1 Heterocyclic sulfonamides as raf inhibitors
09/07/2012WO2012118462A1 Anhydrous crystalline form of tiotropium bromide
09/07/2012WO2012118461A1 Crystalline compound comprising tiotropium bromide
09/07/2012WO2012118460A1 Crystalline compound comprising tiotropium bromide
09/07/2012WO2012118388A1 Peptide-lipid constructs and their use in a fc-function assay
09/07/2012WO2012118309A2 Pyrazole derivatives, preparation method thereof, and composition for preventing and treating osteoporosis containing same
09/07/2012WO2012118308A2 Composition for preventing and treating cardiovascular diseases, containing pyrazole derivative
09/07/2012WO2012118237A1 Anti-cancer prodrug activated by radiation or ultraviolet therapy and use thereof
09/07/2012WO2012118194A1 Pre-filled syringe filling syringe having resin barrel with aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118193A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118192A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118191A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118190A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118172A1 Drug for improving central functions during pain
09/07/2012WO2012118154A1 Novel vitamin d receptor modulator with partial agonist activity
09/07/2012WO2012118139A1 Internal parasiticide
09/07/2012WO2012118068A1 Antineoplastic agent and manufacturing method and use therefor
1 ... 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 ... 7860